Benatti Luca 4
4 · INTERCEPT PHARMACEUTICALS, INC. · Filed May 27, 2022
Insider Transaction Report
Form 4
Benatti Luca
Director
Transactions
- Award
Common Stock
2022-05-25+7,737→ 25,487 total - Award
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 totalExercise: $16.82Exp: 2032-05-25→ Common Stock (12,790 underlying)
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders.
- [F2]All of the options subject to the award shall vest and become exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's 2023 Annual Meeting of Stockholders.